Literature DB >> 7599175

Detection and purification of two 14 kDa phospholipase A2 isoforms in rat kidney: their role in eicosanoid synthesis.

S Hara1, I Kudo, T Komatani, K Takahashi, Y Nakatani, Y Natori, M Ohshima, K Inoue.   

Abstract

Phospholipase A2 (PLA2) activity in the soluble fraction of rat kidney yielded three peaks on DEAE cellulose column chromatography. From these three, we purified two PLA2 isoforms to near-homogeneity. Both had a molecular weight of approx. 14,000 on SDS-PAGE, and immunochemical and enzymological studies indicated that one is a 14 kDa type I PLA2 and the other a 14 kDa type II PLA2. RNA blot analysis confirmed that rat kidney contains both types of PLA2 and that administration of lipopolysaccharides and mercury chloride into rats increased type II PLA2 mRNA levels in kidney. When cultured rat mesangial cells were incubated with purified type I or type II PLA2 in combination with the calcium ionophore A23187 at suboptimal condition, augmentation of prostaglandin E2 production was observed. Type I and type II forms of PLA2 may play a role in arachidonate metabolism in rat kidney.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599175     DOI: 10.1016/0005-2760(95)00011-z

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Cloning and expression of group IB phospholipase A2 isoforms in the red sea bream, Pagrus major.

Authors:  N Iijima; Y Fujikawa; Y Tateishi; Y Takashima; S Uchiyama; M Esaka
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

2.  Purification, characterization, and molecular cloning of group I phospholipases A2 from the gills of the red sea bream, Pagrus major.

Authors:  N Iijima; S Uchiyama; Y Fujikawa; M Esaka
Journal:  Lipids       Date:  2000-12       Impact factor: 1.880

3.  Cross-talk between group IIA-phospholipase A2 and inducible NO-synthase in rat renal mesangial cells.

Authors:  G Rupprecht; K Scholz; K F Beck; H Geiger; J Pfeilschifter; M Kaszkin
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.